Emile Farhan
Corporate Officer/Principal presso AVEO PHARMACEUTICALS, INC.
Provenienza dei contatti di primo grado di Emile Farhan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 47 | |
| Public Company | Pharmaceuticals: Major | 22 | |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN.
7
| Extinct | Pharmaceuticals: Major | 7 |
Veranova LP
1
| Subsidiary | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Emile Farhan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director of Finance/CFO Corporate Officer/Principal Chairman Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member Doctorate Degree Graduate Degree | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal Chief Executive Officer General Counsel Chief Tech/Sci/R&D Officer | |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Founder | |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Chief Executive Officer Founder Founder | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | President Director/Board Member Chairman | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Tufts University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Hitotsubashi | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member Consultant / Advisor Founder | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Founder Founder Founder | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Eisai Corp. of North America
 Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Corp. of North America is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member General Counsel | |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor Chief Investment Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Princeton University | College/University | Corporate Officer/Principal Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel General Counsel | |
Caliper Technologies Corp.
 Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a private company that provides microfluidic technology and laboratory automation solutions to the life science, biotechnology, and pharmaceutical industries worldwide. The company is based in Mountain View, CA. The company was founded by J. Michael Ramsey. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Founder Chairman | |
| ODONATE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer | |
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Founder Founder | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Giappone | 2 |
| Danimarca | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Health Services | 4 |
| Finance | 3 |
Posizioni
| Director/Board Member | 289 |
| Corporate Officer/Principal | 160 |
| Independent Dir/Board Member | 97 |
| Chairman | 56 |
| Undergraduate Degree | 52 |
Contatti più connessi
| Insiders | |
|---|---|
| Anthony Evnin | 46 |
| Henri A. Termeer | 42 |
| John Johnson | 40 |
| Nicholas G. Galakatos | 38 |
| Raju S. Kucherlapati | 27 |
| Mary Lynne Hedley | 25 |
| Dean Mitchell | 22 |
| Robert Epstein | 20 |
| Ronald DePinho | 20 |
| Ken Bate | 19 |
| Gregory Mayes | 18 |
| Erick Lucera | 18 |
| Elan Ezickson | 17 |
| Tuan Ha-Ngoc | 16 |
| Robert C. Young | 15 |
- Borsa valori
- Insiders
- Emile Farhan
- Connessioni Società
